. 2022 May 9;21(1):e127042. doi: 10.5812/ijpr-127042
Copyright © 2022, Author(s)
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Figure 2. An overview of different SARS-CoV-2 vaccine platforms.
